These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3758159)

  • 1. Effects of verapamil on the binding characteristics of muscarinic receptor subtypes.
    Baumgold J
    Eur J Pharmacol; 1986 Jul; 126(1-2):151-4. PubMed ID: 3758159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ; Tran LP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of pirenzepine regional selectivity following solubilization and partial purification of the putative M1 and M2 muscarinic receptor subtypes.
    Baumgold J; Merril C; Gershon ES
    Brain Res; 1987 Apr; 388(1):7-14. PubMed ID: 3580843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of calcium antagonists on muscarinic receptor subtypes in the rat brain.
    Katayama S; Kito S; Miyoshi R; Matsubayashi H
    Brain Res; 1987 Sep; 422(1):168-71. PubMed ID: 3676778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pirenzepine indicates heterogeneity of muscarinic receptors linked to cerebral inositol phospholipid metabolism.
    Lazareno S; Kendall DA; Nahorski SR
    Neuropharmacology; 1985 Jun; 24(6):593-5. PubMed ID: 3839571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of verapamil on the binding properties of rat heart muscarinic receptors: evidence for an allosteric site.
    Waelbroeck M; Robberecht P; De Neef P; Christophe J
    Biochem Biophys Res Commun; 1984 May; 121(1):340-5. PubMed ID: 6732812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of muscarinic cholinergic receptor subtypes in human cortex and pons: implications for anti-motion sickness therapy.
    McCarthy BG; Peroutka SJ
    Aviat Space Environ Med; 1988 Jan; 59(1):63-6. PubMed ID: 3355470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity of muscarinic receptor antagonists for three putative muscarinic receptor binding sites.
    Delmendo RE; Michel AD; Whiting RL
    Br J Pharmacol; 1989 Feb; 96(2):457-64. PubMed ID: 2924085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between muscarinic receptor subtypes and cyclic nucleotides in pons-medulla oblongata.
    Ge XQ; Hu G; Yao B; Xu PC; Bian CF
    Zhongguo Yao Li Xue Bao; 1995 Sep; 16(5):408-11. PubMed ID: 8701755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.
    Cortés R; Probst A; Tobler HJ; Palacios JM
    Brain Res; 1986 Jan; 362(2):239-53. PubMed ID: 3753655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered muscarinic acetylcholine receptor subtype binding in neonatal rat brain following exposure to chlorpyrifos or methyl parathion.
    Guo-Ross SX; Chambers JE; Meek EC; Carr RL
    Toxicol Sci; 2007 Nov; 100(1):118-27. PubMed ID: 17666426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. M1 and M3 muscarinic receptor subtypes in rat forebrain.
    Pavia J; Marquez E; Laukkonen S; Martos F; Gómez A; Sánchez de la Cuesta F
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic studies of [3H]-N-methylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites.
    Waelbroeck M; Gillard M; Robberecht P; Christophe J
    Mol Pharmacol; 1986 Oct; 30(4):305-14. PubMed ID: 3762520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of serotonergic denervation on the density and plasticity of brain muscarinic receptors in the rat.
    Alonso R; Soubrie P
    Synapse; 1991 May; 8(1):30-7. PubMed ID: 1714634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of muscarinic receptors in human, guinea pig and rat lung.
    Gies JP; Bertrand C; Vanderheyden P; Waeldele F; Dumont P; Pauli G; Landry Y
    J Pharmacol Exp Ther; 1989 Jul; 250(1):309-15. PubMed ID: 2746503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.
    Waelbroeck M; Gillard M; Robberecht P; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):91-9. PubMed ID: 3600616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secoverine is a non-selective muscarinic antagonist on rat heart and brain receptors.
    Brunner F; Waelbroeck M; Christophe J
    Eur J Pharmacol; 1986 Aug; 127(1-2):17-25. PubMed ID: 3758175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the interaction of gallamine with muscarinic receptor subtypes.
    Michel AD; Delmendo RE; Lopez M; Whiting RL
    Eur J Pharmacol; 1990 Jul; 182(2):335-45. PubMed ID: 2397745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.